In addition, CXCR4 expression correlates with the degree of tumor infiltration and promotes a more aggressive phenotype in papillary thyroid carcinoma [208], and is also a negative prognostic marker for response to chemotherapy in NHL [209]. Here, CXCR4 is linked to non-Hodgkin lymphoma.